Erratum: RhoE Is a Pro-Survival p53 Target Gene that Inhibits ROCK I-Mediated Apoptosis in Response to Genotoxic Stress (Current Biology (2012) 22(22) (2186–2187)(S0960982206024316)(10.1016/j.cub.2006.10.056));RhoE Is a Pro-Survival p53 Target Gene that Inhibits ROCK I-Mediated Apoptosis in Response to Genotoxic Stress

Current Biology

Volumn 16, Issue 24, 2006, Pages 2466-2472

  Ongusaha, Pat P ^a   Kim, Hyung Gu ^a   Boswell, Sarah A ^a   Ridley, Anne J ^b   Der, Channing J ^c   Dotto, G Paolo ^a   Kim, Young Bum ^a   Aaronson, Stuart A ^d   Lee, Sam W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CELLBIO; CELLCYCLE

Indexed keywords

APSEUDES;

EID: 33845420563     PISSN: 09609822     EISSN: 18790445     Source Type: Journal    
DOI: 10.1016/j.cub.2016.07.072     Document Type: Erratum

References (28)

1. Etienne-Manneville S., and Hall A. Rho GTPases in cell biology. Nature 420 (2002) 629-635
2. Sahai E., and Marshall C.J. RHO-GTPases and cancer. Nat. Rev. Cancer 2 (2002) 133-142
3. Schmidt A., and Hall A. Guanine nucleotide exchange factors for Rho GTPases: Turning on the switch. Genes Dev. 16 (2002) 1587-1609
4. Moon S.Y., and Zheng Y. Rho GTPase-activating proteins in cell regulation. Trends Cell Biol. 13 (2003) 13-22
5. Coleman M.L., Marshall C.J., and Olson M.F. RAS and RHO GTPases in G1-phase cell-cycle regulation. Nat. Rev. Mol. Cell Biol. 5 (2004) 355-366
6. Chardin P. GTPase regulation: Getting aRnd Rock and Rho inhibition. Curr. Biol. 13 (2003) R702-R704
7. Foster R., Hu K.Q., Lu Y., Nolan K.M., Thissen J., and Settleman J. Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation. Mol. Cell. Biol. 16 (1996) 2689-2699
8. Guasch R.M., Scambler P., Jones G.E., and Ridley A.J. RhoE regulates actin cytoskeleton organization and cell migration. Mol. Cell. Biol. 18 (1998) 4761-4771
9. Nobes C.D., Lauritzen I., Mattei M.G., Paris S., Hall A., and Chardin P. A new member of the Rho family, Rnd1, promotes disassembly of actin filament structures and loss of cell adhesion. J. Cell Biol. 141 (1998) 187-197
10. Chardin P. Function and regulation of Rnd proteins. Nat. Rev. Mol. Cell Biol. 7 (2006) 54-62
11. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
12. Riento K., Guasch R.M., Garg R., Jin B., and Ridley A.J. RhoE binds to ROCK I and inhibits downstream signaling. Mol. Cell. Biol. 23 (2003) 4219-4229
13. Villalonga P., Guasch R.M., Riento K., and Ridley A.J. RhoE inhibits cell cycle progression and Ras-induced transformation. Mol. Cell. Biol. 24 (2004) 7829-7840
14. Sebbagh M., Renvoize C., Hamelin J., Riche N., Bertoglio J., and Breard J. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat. Cell Biol. 3 (2001) 346-352
15. Coleman M.L., Sahai E.A., Yeo M., Bosch M., Dewar A., and Olson M.F. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3 (2001) 339-345
16. Coleman M.L., and Olson M.F. Rho GTPase signalling pathways in the morphological changes associated with apoptosis. Cell Death Differ. 9 (2002) 493-504
17. Lane J.D., Allan V.J., and Woodman P.G. Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J. Cell Sci. 118 (2005) 4059-4071
18. Croft D.R., Coleman M.L., Li S., Robertson D., Sullivan T., Stewart C.L., and Olson M.F. Actin-myosin-based contraction is responsible for apoptotic nuclear disintegration. J. Cell Biol. 168 (2005) 245-255
19. Riento K., Totty N., Villalonga P., Garg R., Guasch R., and Ridley A.J. RhoE function is regulated by ROCK I-mediated phosphorylation. EMBO J. 24 (2005) 1170-1180
20. Lai J.M., Hsieh C.L., and Chang Z.F. Caspase activation during phorbol ester-induced apoptosis requires ROCK-dependent myosin-mediated contraction. J. Cell Sci. 116 (2003) 3491-3501
21. Minambres R., Guasch R.M., Perez-Arago A., and Guerri C. The RhoA/ROCK-I/MLC pathway is involved in the ethanol-induced apoptosis by anoikis in astrocytes. J. Cell Sci. 119 (2006) 271-282
22. Zihni C., Mitsopoulos C., Tavares I.A., Ridley A.J., and Morris J.D. Prostate-derived sterile 20-like kinase 2 (PSK2) regulates apoptotic morphology via C-Jun N-terminal kinase and RHO kinase-1. J. Biol. Chem. 281 (2006) 7317-7323
23. Chang J., Xie M., Shah V.R., Schneider M.D., Entman M.L., Wei L., and Schwartz R.J. Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis. Proc. Natl. Acad. Sci. USA 103 (2006) 14495-14500
24. Takahara A., Sugiyama A., Satoh Y., Yoneyama M., and Hashimoto K. Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model. Eur. J. Pharmacol. 460 (2003) 51-57
25. Bektic J., Pfeil K., Berger A.P., Ramoner R., Pelzer A., Schafer G., Kofler K., Bartsch G., and Klocker H. Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis. Prostate 64 (2005) 332-340
26. Gress T.M., Muller-Pillasch F., Geng M., Zimmerhackl F., Zehetner G., Friess H., Buchler M., Adler G., and Lehrach H. A pancreatic cancer-specific expression profile. Oncogene 13 (1996) 1819-1830
27. van Groningen J.J., Cornelissen I.M., van Muijen G.N., Bloemers H.P., and Swart G.W. Simultaneous suppression of progression marker genes in the highly malignant human melanoma cell line BLM after transfection with the adenovirus-5 E1A gene. Biochem. Biophys. Res. Commun. 225 (1996) 808-816
28. Akashi H., Han H.J., Iizaka M., and Nakamura Y. Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac. Int. J. Cancer 88 (2000) 873-880